177 related articles for article (PubMed ID: 27422086)
1. A Novel Disintegration Tester for Solid Dosage Forms Enabling Adjustable Hydrodynamics.
Kindgen S; Rach R; Nawroth T; Abrahamsson B; Langguth P
J Pharm Sci; 2016 Aug; 105(8):2402-9. PubMed ID: 27422086
[TBL] [Abstract][Full Text] [Related]
2. Computational Fluid Dynamics Simulation of Hydrodynamics and Stresses in the PhEur/USP Disintegration Tester Under Fed and Fasted Fluid Characteristics.
Kindgen S; Wachtel H; Abrahamsson B; Langguth P
J Pharm Sci; 2015 Sep; 104(9):2956-68. PubMed ID: 26017815
[TBL] [Abstract][Full Text] [Related]
3. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
Desai PM; Liew CV; Heng PW
Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
[TBL] [Abstract][Full Text] [Related]
4. Computational fluid dynamics simulation of hydrodynamics in USP apparatus 3-the influence of dip rate.
Perivilli S; Kakhi M; Stippler E
Pharm Res; 2015 Apr; 32(4):1304-15. PubMed ID: 25407541
[TBL] [Abstract][Full Text] [Related]
5. Bio-predictive tablet disintegration: effect of water diffusivity, fluid flow, food composition and test conditions.
Radwan A; Wagner M; Amidon GL; Langguth P
Eur J Pharm Sci; 2014 Jun; 57():273-9. PubMed ID: 24036239
[TBL] [Abstract][Full Text] [Related]
6. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
[TBL] [Abstract][Full Text] [Related]
7. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
Hooper P; Lasher J; Alexander KS; Baki G
J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of disintegration rate is important for predicting the oral absorption of solid dosage forms containing poorly soluble weak base drugs.
Nakamura K; Kambayashi A; Onoue S
Eur J Pharm Biopharm; 2022 Nov; 180():23-32. PubMed ID: 36154905
[TBL] [Abstract][Full Text] [Related]
9. Visual Monitoring of Disintegration of Solid Oral Dosage Forms in Simulated Gastric Fluids Using Low-Field NMR Imaging.
Ye Q; Ding M; Zhang P; Wu P; Wang Y; Selomulya C; Chen XD
AAPS PharmSciTech; 2022 Sep; 23(7):246. PubMed ID: 36050431
[TBL] [Abstract][Full Text] [Related]
10. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
11. Characterising the disintegration properties of tablets in opaque media using texture analysis.
Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
Hoashi Y; Tozuka Y; Takeuchi H
Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
[TBL] [Abstract][Full Text] [Related]
14. Development of a digital twin of a tablet that mimics a real solid dosage form: Differences in the dissolution profile in conventional mini-USP II and a biorelevant colon model.
Schütt M; Stamatopoulos K; Batchelor HK; Simmons MJH; Alexiadis A
Eur J Pharm Sci; 2022 Dec; 179():106310. PubMed ID: 36265815
[TBL] [Abstract][Full Text] [Related]
15. Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions.
Lenz J; Fuest F; Finke JH; Bunjes H; Kwade A; Juhnke M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057103
[TBL] [Abstract][Full Text] [Related]
16. Computational hydrodynamic comparison of a mini vessel and a USP 2 dissolution testing system to predict the dynamic operating conditions for similarity of dissolution performance.
Wang B; Bredael G; Armenante PM
Int J Pharm; 2018 Mar; 539(1-2):112-130. PubMed ID: 29341921
[TBL] [Abstract][Full Text] [Related]
17. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
Koner JS; Rajabi-Siahboomi AR; Missaghi S; Kirby D; Perrie Y; Ahmed J; Mohammed AR
Sci Rep; 2019 Aug; 9(1):12467. PubMed ID: 31462654
[TBL] [Abstract][Full Text] [Related]
18. Using Computational Fluid Dynamics to Compare Shear Rate and Turbulence in the TIM-Automated Gastric Compartment With USP Apparatus II.
Hopgood M; Reynolds G; Barker R
J Pharm Sci; 2018 Jul; 107(7):1911-1919. PubMed ID: 29608886
[TBL] [Abstract][Full Text] [Related]
19. Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.
Koziolek M; Görke K; Neumann M; Garbacz G; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():250-6. PubMed ID: 24051217
[TBL] [Abstract][Full Text] [Related]
20. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
